Page v1 vof v822
Test Bank for Basic and Clinical Pharmacology 14th Edition
v v v v v v v v
v by Bertram G. Katzung
v v v v
Chapters 1 - 66 Complete
v v v v
, Page v2 vof v822
Table of Contents
v v
1. vIntroduction: vThe vNature vof vDrugs v& vDrug vDevelopment v& vRegulation
2. vDrug vReceptors v& vPharmacodynamics
3. vPharmacokinetics v& vPharmacodynamics: vRational vDosing v& vthe vTime vCourse vof vDrug vAction
4. vDrug vBiotransformation
5. vPharmacogenomics
6. vIntroduction vto vAutonomic vPharmacology
7. vCholinoceptor-Activating v& vCholinesterase-Inhibiting vDrugs
8. vCholinoceptor-Blocking vDrugs
9. vAdrenoceptor vAgonists v& vSympathomimetic vDrugs
10. vAdrenoceptor vAntagonist vDrugs
11. vAntihypertensive vAgents
12. vVasodilators v& vthe vTreatment vof vAngina vPectoris
13. vDrugs vUsed vin vHeart vFailure
14. vAgents vUsed vin vCardiac vArrhythmias
15. vDiuretic vAgents
16. vHistamine, vSerotonin, v& vthe vErgot vAlkaloids
17. vVasoactive vPeptides
18. vThe vEicosanoids: vProstaglandins, vThromboxanes, vLeukotrienes, v& vRelated vCompounds
19. vNitric vOxide
20. vDrugs vUsed vin vAsthma
21. vIntroduction vto vthe vPharmacology vof vCNS vDrugs
22. vSedative-Hypnotic vDrugs
23. vThe vAlcohols
24. vAntiseizure vDrugs
25. vGeneral vAnesthetics
26. vLocal vAnesthetics
27. vSkeletal vMuscle vRelaxants
28. vPharmacologic vManagement vof vParkinsonism v& vOther vMovement vDisorders
29. vAntipsychotic vAgents v& vLithium
30. vAntidepressant vAgents
31. vOpioid vAgonists v& vAntagonists
32. vDrugs vof vAbuse
33. vAgents vUsed vin vCytopenias; vHematopoietic vGrowth vFactors
34. vDrugs vUsed vin vDisorders vof vCoagulation
35. vAgents vUsed vin vDyslipidemia
36. vNonsteroidal vAnti-Inflammatory vDrugs, vDisease-Modifying vAntirheumatic vDrugs, vNonopioid vAnalgesics, v&
, Page v3 vof v822
Drugs vUsed vin vGout
v
37. vHypothalamic v& vPituitary vHormones
38. vThyroid v& vAntithyroid vDrugs
39. vAdrenocorticosteroids v& vAdrenocortical vAntagonists
40. vThe vGonadal vHormones v& vInhibitors
41. vPancreatic vHormones v& vAntidiabetic vDrugs
42. vAgents vThat vAffect vBone vMineral vHomeostasis
43. vBeta-Lactam v& vOther vCell vWall- v& vMembrane-Active vAntibiotics
44. vTetracyclines, vMacrolides, vClindamycin, vChloramphenicol, vStreptogramins, v& vOxazolidinones
45. vAminoglycosides v& vSpectinomycin
46. vSulfonamides, vTrimethoprim, v& vQuinolones
47. vAntimycobacterial vDrugs
48. vAntifungal vAgents
49. vAntiviral vAgents
50. vMiscellaneous vAntimicrobial vAgents; vDisinfectants, vAntiseptics, v& vSterilants
51. vClinical vUse vof vAntimicrobial vAgents
52. vAntiprotozoal vDrugs
53. vClinical vPharmacology vof vthe vAntihelminthic vDrugs
54. vCancer vChemotherapy
55. vImmunopharmacology
56. vIntroduction vto vToxicology: vOccupational v& vEnvironmental
57. vHeavy vMetal vIntoxication v& vChelators
58. vManagement vof vthe vPoisoned vPatient
59. vSpecial vAspects vof vPerinatal v& vPediatric vPharmacology
60. vSpecial vAspects vof vGeriatric vPharmacology
61. vDermatologic vPharmacology
62. vDrugs vUsed vin vthe vTreatment vof vGastrointestinal vDiseases
63. vTherapeutic v& vToxic vPotential vof vOver-the-Counter vAgents
64. vDietary vSupplements v& vHerbal vMedications
65. vRational vPrescribing v& vPrescription vWriting
66. vImportant vDrug vInteractions v& vTheir vMechanisms v
, Page v4 vof v822
Chapter 1. Introduction: The Nature of Drugs & Drug Development & Regulation
v v v v v v v v v v v
1. A vnurse vworking vin vradiology vadministers viodine vto va vpatient vwho vis
vhaving va vcomputed vtomography v(CT) vscan. vThe vnurse vworking von vthe
voncology vunit vadministers vchemotherapy vto vpatients vwho vhave vcancer.
vAt vthe vPublic vHealth vDepartment, va vnurse vadministers va vmeasles-
mumps-rubella v(MMR) vvaccine vtova v14-month-old vchild vas va vroutine
vimmunization. vWhich vbranch vof vpharmacology vbest vdescribes vthe vactions
vof vall vthree v nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology vis vthe vstudy vof vthe vbiologic veffects vof vchemicals. vNurses
vare vinvolved vwith vclinical vpharmacology vor vpharmacotherapeutics, vwhich
vis va vbranch vof vpharmacology vthat vdeals vwith vthe vuses vof v drugs vto vtreat,
vprevent, vand vdiagnose vdisease. vThe vradiology vnurse vis vadministering va
vdrug vto vhelp vdiagnose va vdisease. vThe voncology vnurse vis vadministering va
vdrug vto vhelp vtreat vavdisease. vPharmacoeconomics vincludes vany vcosts
vinvolved vin vdrug v therapy.
Pharmacodynamics vinvolves vhow va vdrug vaffects vthe vbody
vandvpharmacokinetics vis vhow vthe vbody vacts von vthe vbody.
2. A vphysician vhas vordered vintramuscular v(IM) vinjections vof vmorphine, va
vnarcotic, vevery v4 vhours vas vneeded vfor vpain vin va vmotor vvehicle vaccident
vvictim.vThe vnurse v is vaware vthis vdrug vhas va vhigh vabuse vpotential. vUnder
vwhat vcategoryvwould vmorphine vbe v classified?
A) Schedule vI
B) Schedule vII
Test Bank for Basic and Clinical Pharmacology 14th Edition
v v v v v v v v
v by Bertram G. Katzung
v v v v
Chapters 1 - 66 Complete
v v v v
, Page v2 vof v822
Table of Contents
v v
1. vIntroduction: vThe vNature vof vDrugs v& vDrug vDevelopment v& vRegulation
2. vDrug vReceptors v& vPharmacodynamics
3. vPharmacokinetics v& vPharmacodynamics: vRational vDosing v& vthe vTime vCourse vof vDrug vAction
4. vDrug vBiotransformation
5. vPharmacogenomics
6. vIntroduction vto vAutonomic vPharmacology
7. vCholinoceptor-Activating v& vCholinesterase-Inhibiting vDrugs
8. vCholinoceptor-Blocking vDrugs
9. vAdrenoceptor vAgonists v& vSympathomimetic vDrugs
10. vAdrenoceptor vAntagonist vDrugs
11. vAntihypertensive vAgents
12. vVasodilators v& vthe vTreatment vof vAngina vPectoris
13. vDrugs vUsed vin vHeart vFailure
14. vAgents vUsed vin vCardiac vArrhythmias
15. vDiuretic vAgents
16. vHistamine, vSerotonin, v& vthe vErgot vAlkaloids
17. vVasoactive vPeptides
18. vThe vEicosanoids: vProstaglandins, vThromboxanes, vLeukotrienes, v& vRelated vCompounds
19. vNitric vOxide
20. vDrugs vUsed vin vAsthma
21. vIntroduction vto vthe vPharmacology vof vCNS vDrugs
22. vSedative-Hypnotic vDrugs
23. vThe vAlcohols
24. vAntiseizure vDrugs
25. vGeneral vAnesthetics
26. vLocal vAnesthetics
27. vSkeletal vMuscle vRelaxants
28. vPharmacologic vManagement vof vParkinsonism v& vOther vMovement vDisorders
29. vAntipsychotic vAgents v& vLithium
30. vAntidepressant vAgents
31. vOpioid vAgonists v& vAntagonists
32. vDrugs vof vAbuse
33. vAgents vUsed vin vCytopenias; vHematopoietic vGrowth vFactors
34. vDrugs vUsed vin vDisorders vof vCoagulation
35. vAgents vUsed vin vDyslipidemia
36. vNonsteroidal vAnti-Inflammatory vDrugs, vDisease-Modifying vAntirheumatic vDrugs, vNonopioid vAnalgesics, v&
, Page v3 vof v822
Drugs vUsed vin vGout
v
37. vHypothalamic v& vPituitary vHormones
38. vThyroid v& vAntithyroid vDrugs
39. vAdrenocorticosteroids v& vAdrenocortical vAntagonists
40. vThe vGonadal vHormones v& vInhibitors
41. vPancreatic vHormones v& vAntidiabetic vDrugs
42. vAgents vThat vAffect vBone vMineral vHomeostasis
43. vBeta-Lactam v& vOther vCell vWall- v& vMembrane-Active vAntibiotics
44. vTetracyclines, vMacrolides, vClindamycin, vChloramphenicol, vStreptogramins, v& vOxazolidinones
45. vAminoglycosides v& vSpectinomycin
46. vSulfonamides, vTrimethoprim, v& vQuinolones
47. vAntimycobacterial vDrugs
48. vAntifungal vAgents
49. vAntiviral vAgents
50. vMiscellaneous vAntimicrobial vAgents; vDisinfectants, vAntiseptics, v& vSterilants
51. vClinical vUse vof vAntimicrobial vAgents
52. vAntiprotozoal vDrugs
53. vClinical vPharmacology vof vthe vAntihelminthic vDrugs
54. vCancer vChemotherapy
55. vImmunopharmacology
56. vIntroduction vto vToxicology: vOccupational v& vEnvironmental
57. vHeavy vMetal vIntoxication v& vChelators
58. vManagement vof vthe vPoisoned vPatient
59. vSpecial vAspects vof vPerinatal v& vPediatric vPharmacology
60. vSpecial vAspects vof vGeriatric vPharmacology
61. vDermatologic vPharmacology
62. vDrugs vUsed vin vthe vTreatment vof vGastrointestinal vDiseases
63. vTherapeutic v& vToxic vPotential vof vOver-the-Counter vAgents
64. vDietary vSupplements v& vHerbal vMedications
65. vRational vPrescribing v& vPrescription vWriting
66. vImportant vDrug vInteractions v& vTheir vMechanisms v
, Page v4 vof v822
Chapter 1. Introduction: The Nature of Drugs & Drug Development & Regulation
v v v v v v v v v v v
1. A vnurse vworking vin vradiology vadministers viodine vto va vpatient vwho vis
vhaving va vcomputed vtomography v(CT) vscan. vThe vnurse vworking von vthe
voncology vunit vadministers vchemotherapy vto vpatients vwho vhave vcancer.
vAt vthe vPublic vHealth vDepartment, va vnurse vadministers va vmeasles-
mumps-rubella v(MMR) vvaccine vtova v14-month-old vchild vas va vroutine
vimmunization. vWhich vbranch vof vpharmacology vbest vdescribes vthe vactions
vof vall vthree v nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology vis vthe vstudy vof vthe vbiologic veffects vof vchemicals. vNurses
vare vinvolved vwith vclinical vpharmacology vor vpharmacotherapeutics, vwhich
vis va vbranch vof vpharmacology vthat vdeals vwith vthe vuses vof v drugs vto vtreat,
vprevent, vand vdiagnose vdisease. vThe vradiology vnurse vis vadministering va
vdrug vto vhelp vdiagnose va vdisease. vThe voncology vnurse vis vadministering va
vdrug vto vhelp vtreat vavdisease. vPharmacoeconomics vincludes vany vcosts
vinvolved vin vdrug v therapy.
Pharmacodynamics vinvolves vhow va vdrug vaffects vthe vbody
vandvpharmacokinetics vis vhow vthe vbody vacts von vthe vbody.
2. A vphysician vhas vordered vintramuscular v(IM) vinjections vof vmorphine, va
vnarcotic, vevery v4 vhours vas vneeded vfor vpain vin va vmotor vvehicle vaccident
vvictim.vThe vnurse v is vaware vthis vdrug vhas va vhigh vabuse vpotential. vUnder
vwhat vcategoryvwould vmorphine vbe v classified?
A) Schedule vI
B) Schedule vII
